Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nucleolar RNA SNORD77 (SNORD77) is a non-coding RNA belonging to the snoRNA class and is not a protein but a functional RNA molecule[4]. SnoRNAs like SNORD77 typically serve as guide RNAs for the modification (mainly 2'-O-methylation) of ribosomal RNAs and small nuclear RNAs, playing an essential role in RNA processing and maturation. There is no evidence that this molecule serves as a therapeutic target, is associated with drug activity, or is used as a biomarker in clinical settings[4]. According to genomic sources, nothing is formally wrong with the spelling, identifier, or mapping of this entry, but it is not considered a therapeutic target molecule, protein, enzyme, or receptor. Its main function is as a guide RNA for RNA modification within the nucleolus[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nucleolar RNA SNORD77 (SNORD77).